Abstract
TREX1 acts in concert with the SET complex in granzyme A–mediated apoptosis, and mutations in TREX1 cause Aicardi-Goutières syndrome and familial chilblain lupus. Here, we report monoallelic frameshift or missense mutations and one 3′ UTR variant of TREX1 present in 9/417 individuals with systemic lupus erythematosus but absent in 1,712 controls (P = 4.1 × 10−7). We demonstrate that two mutant TREX1 alleles alter subcellular targeting. Our findings implicate TREX1 in the pathogenesis of SLE.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Characteristics and genetic analysis of patients suspected with early-onset systemic lupus erythematosus
Pediatric Rheumatology Open Access 13 August 2022
-
Structural basis of human TREX1 DNA degradation and autoimmune disease
Nature Communications Open Access 25 July 2022
-
High clinical heterogeneity in a Chinese pedigree of retinal vasculopathy with cerebral leukoencephalopathy and systemic manifestations (RVCL-S)
Orphanet Journal of Rare Diseases Open Access 30 January 2021
Access options
Subscribe to Journal
Get full journal access for 1 year
$79.00
only $6.58 per issue
All prices are NET prices.
VAT will be added later in the checkout.
Tax calculation will be finalised during checkout.
Buy article
Get time limited or full article access on ReadCube.
$32.00
All prices are NET prices.

References
Mazur, D.J. & Perrino, F.W. J. Biol. Chem. 274, 19655–19660 (1999).
Chowdhury, D. et al. Mol. Cell 23, 133–142 (2006).
Crow, Y.J. et al. Nat. Genet. 38, 917–920 (2006).
Rice, G. et al. Am. J. Hum. Genet. 80, 811–815 (2007).
Morita, M. et al. Mol. Cell. Biol. 24, 6719–6727 (2004).
Laan, M. & Paabo, S. Nat. Genet. 17, 435–438 (1997).
Boe, S.O. et al. J. Cell Sci. 119, 3284–3295 (2006).
Regad, T. & Chelbi-Alix, M.K. Oncogene 20, 7274–7286 (2001).
de Silva, U. et al. J. Biol. Chem. 282, 10537–10543 (2007).
Mendell, J.T. & Dietz, H.C. Cell 107, 411–414 (2001).
James, J.A., Harley, J.B. & Scofield, R.H. Curr. Opin. Rheumatol. 13, 370–376 (2001).
Stetson, D.B. & Medzhitov, R. Immunity 24, 93–103 (2006).
Napirei, M. et al. Nat. Genet. 25, 177–181 (2000).
Yasutomo, K. et al. Nat. Genet. 28, 313–314 (2001).
Kawane, K. et al. Nature 443, 998–1002 (2006).
Acknowledgements
We thank all subjects for participation in this study. We thank W.L. Gross, E. Gromnica-Ihle, H.-H. Peter, S. Schnarr and M. Linné for clinical assistance. We acknowledge technical assistance of C. Flachmeier, M. Schwarz and A. Müller. We thank M. Weber at the Technische Universität Dresden confocal microscopy core facility. We thank M.T. Pisabarro, K. Köhler, M.C. Cardoso and F.C. Luft for helpful discussions and comments. This work was supported by a Marie Curie Development Host Fellowship from the European Commission to M.A.L.-K., a grant from the German Ministry of Science and Education (BMBF Kompetenznetz Rheuma C2.12) to T.W., US National Institutes of Health (NIH) grant AI45587 to J.L., NIH grant GM069962 to F.W.P. and a grant-in-aid from the National Genome Research Network (NGFN2) of the German Ministry of Science and Education (BMBF) to Y.-A.L. and N.H.
Author information
Authors and Affiliations
Contributions
M.A.L.-K. developed the project. M.A.L.-K. and N.H. codirected the project. M.G., K.E., L.S., Y.-A.L. and O.H. performed mutation screening. F.W.P., U.d.S., S.L.B., S.H. and T.H. generated bacterial expression constructs, performed biochemical analysis of recombinant TREX1 and generated the structural model of TREX1. L.S. and K.E. generated mammalian expression constructs and performed transfection and immune histochemistry. D.C. and J.L. performed studies on granzyme A–mediated apoptosis. T.J.V., A.W., J.K., S.K., T.W., R.E.S., A.F.D., M.G. and C.P. contributed individuals with SLE or controls. K.R. performed statistical analysis. M.A.L.-K. wrote the paper with J.L. and N.H.
Corresponding authors
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Supplementary information
Supplementary Text and Figures
Supplementary Tables 1–2, Supplementary Figures 1–3, Supplementary Methods (PDF 200 kb)
Rights and permissions
About this article
Cite this article
Lee-Kirsch, M., Gong, M., Chowdhury, D. et al. Mutations in the gene encoding the 3′-5′ DNA exonuclease TREX1 are associated with systemic lupus erythematosus. Nat Genet 39, 1065–1067 (2007). https://doi.org/10.1038/ng2091
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/ng2091
This article is cited by
-
Characteristics and genetic analysis of patients suspected with early-onset systemic lupus erythematosus
Pediatric Rheumatology (2022)
-
Emerging concepts of type I interferons in SLE pathogenesis and therapy
Nature Reviews Rheumatology (2022)
-
The type I interferonopathies: 10 years on
Nature Reviews Immunology (2022)
-
Structural basis of human TREX1 DNA degradation and autoimmune disease
Nature Communications (2022)
-
Role of the cGAS–STING pathway in systemic and organ-specific diseases
Nature Reviews Nephrology (2022)